PR Newswire
VANCOUVER, Canada and
HOUSTON, Texas
,
Aug. 31, 2021
/PRNewswire/ – ESSA Pharma Inc. (“ESSA”, or the “Company”) (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that
David R. Parkinson
, President and Chief Executive Officer of ESSA Pharma, will be presenting and hosting one-on-one meetings with investors at two upcoming virtual investor conferences.
Peter Virsik
, ESSA’s Chief Operating Officer, and
David S. Wood
, ESSA’s Chief Financial Officer, will also be available for one-on-one meetings.
Presentation Details
Event:
H.C. Wainwright Annual Global Investment Conference
Date:
Monday, September 13, 2021
Time (on-demand):
7:00 a.m. ET
Event
: Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
Date:
Tuesday, September 21, 2021
Time:
9:
05 a.m. ET
Webcasts of the events can be accessed in the Investors/Events & Presentations section of ESSA’s website at
www.essapharma.com
. Following the events, the webcasts will be archived on the ESSA website for 90 days.
About ESSA Pharma Inc.
ESSA is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer. For more information, please visit
www.essapharma.com
and follow us on Twitter under
@ESSAPharma
.
View original content:
https://www.prnewswire.com/news-releases/essa-pharma-to-present-at-upcoming-september-investor-conferences-301366567.html
SOURCE ESSA Pharma Inc
